Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10036)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Oct 14, 2019 (publication date) through Apr 20, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Parra RS, Chebli JM, Amarante HM, Flores C, Parente JM, Ramos O, Fernandes M, Rocha JJ, Feitosa MR, Feres O, Scotton AS, Nones RB, Lima MM, Zaltman C, Goncalves CD, Guimaraes IM, Santana GO, Sassaki LY, Hossne RS, Bafutto M, Junior RL, Faria MA, Miszputen SJ, Gomes TN, Catapani WR, Faria AA, Souza SC, Caratin RF, Senra JT, Ferrari ML. Quality of life, work productivity impairment and healthcare resources in inflammatory bowel diseases in Brazil. World J Gastroenterol 2019; 25(38): 5862-5882 [PMID: 31636478 DOI: 10.3748/wjg.v25.i38.5862] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v25/i38/5862.htm |
| Number | Citing Articles |
| 1 |
Anna Kernder, Christina Düsing, Jutta Richter, Ralph Brinks, Rebecca Fischer-Betz, Borgi Winkler-Rohlfing, Martin Aringer, Matthias Schneider, Gamal Chehab. Factors detrimental to work productivity and daily activities in systemic lupus erythematosus patients – Analysis of the German LuLa study. Lupus 2021; 30(12): 1931 doi: 10.1177/09612033211045063
|
| 2 |
Jose María Huguet, Xavier Cortés, Marta Maia Bosca-Watts, Marian Aguas, Nuria Maroto, Lidia Martí, Cirilo Amorós, Jose María Paredes. Real-world data on the infliximab biosimilar CT-P13 (Remsima<sup>®</sup>) in inflammatory bowel disease. World Journal of Clinical Cases 2021; 9(36): 11285-11299 doi: 10.12998/wjcc.v9.i36.11285
|
| 3 |
Tarcia Nogueira Ferreira Gomes, Fabio Silva de Azevedo, Marjorie Argollo, Sender Jankiel Miszputen, Orlando Ambrogini JR. Clinical and Demographic Profile of Inflammatory Bowel Disease Patients in a Reference Center of São Paulo, Brazil. Clinical and Experimental Gastroenterology 2021; : 91 doi: 10.2147/CEG.S288688
|
| 4 |
Valentina Petito, Federica Di Vincenzo, Lorenza Putignani, Maria T. Abreu, Birgitte Regenberg, Antonio Gasbarrini, Franco Scaldaferri. Extrachromosomal Circular DNA: An Emerging Potential Biomarker for Inflammatory Bowel Diseases?. Genes 2024; 15(4): 414 doi: 10.3390/genes15040414
|
| 5 |
Hassan Karami, Farbod Ebadi Fard Azar, Kamran Bagheri Lankarani, Aziz Rezapour, Sulmaz Ghahramani, Abdolvahab Baghbanian. Adalimumab versus Infliximab Treatment Outcome in Ulcerative Colitis: Application of EQ-5D, Visual Analogue Scale, and IBDQ-9 Measures: A Prospective Observational Study. Current Drug Safety 2023; 18(4): 484 doi: 10.2174/1574886317666220526153518
|
| 6 |
Nathalie Touma, Louise Zanni, Pierre Blanc, Guillaume Savoye, Carolina Baeza-Velasco. «Digesting Crohn’s Disease»: The Journey of Young Adults since Diagnosis. Journal of Clinical Medicine 2023; 12(22): 7128 doi: 10.3390/jcm12227128
|
| 7 |
J Moreau, N Hammoudi, L Marthey, C Trang-Poisson, M Nachury, R Altwegg, J C Grimaud, S Orempuller, X Hébuterne, A Aubourg, C Baudry, P Seksik, X Roblin, S Nahon, G Savoye, B Mesnard, C Stefanescu, M Simon, B Coffin, M Fumery, F Carbonnel, L Peyrin-Biroulet, K Desseaux, M Allez, Franck Brazier, Jean-Louis Dupas, Mathurin Fumery, Martine Leconte, Annie Bornet, Yoram Bouhnik, Geraldine Herbet, Suzanna Ostrec, Carmen Stefanescu, Xavier Treton, Benoît Coffin, Delphine Coutarel, Joséphanne Romarin, Franck Carbonnel, Lysiane Marthey, Valérie Kail, Maria Nachury, Benjamin Pariente, Stéphanie Challier, Mylène Ducerne, Jean-Charles Grimaud, Isabelle Lutgen, Valérie Lebayle, Laetitia Legoux, Stéphane Nahon, Romain Altwegg, Ludovic Caillo, Laurent Peyrin-Biroulet, Nelly Benard, Béatrice Boucard, Arnaud Bourreille, Elise Kerdreux, Katia Ferreira, Caroline Trang-Poisson, Nadia Arab, Virginie Cluzeau, Evalyne Eyraud, Jerôme Filippi, Xavier Hébuterne, Aurore Paput, Amine Rahill, Laura Armengol-De Beir, Julien Blot, Elise Foloppe, Guillaume Savoye, Gaëlle Vienney, Marion Simon, Laurent Beaugerie, Anne Bourrier, Najim Chafai, Clotilde Debove, Nadia Hoyeau, Julien Kirchgesner, Cécilia Landman, Jérémie H Lefèvre, Isabelle Nion-Larmurier, Yann Parc, Philippe Seksik, Harry Sokol, Matthieu Allez, Clotilde Baudry, Joëlle Bonnet, Leïla Chedouba, Nathalie Descrouet, Nassim Hammoudi, Jean-Félix Lepasteur, Andrée Nisard, Marion Vincent, Sylvie Chevret, Kristell Desseaux, Regine Berolo, Emilie Del Tedesco, Xavier Roblin, Emilie Bergereau, Patrick Faure, Audrey Haenning, Marianne Lassailly, Jacques Moreau, Sandra Orempuller, Bruno Mesnard, Souheyla Mezrag Biskri, Noémie Tavernier, Floriane Verhaeghe, Gwenola Vernier, Alexandre Aubourg, Magalie Chauvigneau, Charles Lamblin, Marie-Christine Lorin, Laurence Picon. Impact of an Education Programme on IBD Patients’ Skills: Results of a Randomised Controlled Multicentre Study [ECIPE]. Journal of Crohn's and Colitis 2021; 15(3): 432 doi: 10.1093/ecco-jcc/jjaa195
|
| 8 |
Matthew J Brookes, John Waller, Joseph C Cappelleri, Irene Modesto, Marco D DiBonaventura, Natalie Bohm, Ruth Mokgokong, Olivia Massey, Robert Wood, Danielle Bargo. Living with Ulcerative Colitis Study (LUCY) in England: a retrospective study evaluating healthcare resource utilisation and direct healthcare costs of postoperative care in ulcerative colitis. BMJ Open Gastroenterology 2020; 7(1): e000456 doi: 10.1136/bmjgast-2020-000456
|
| 9 |
Simona Gatti, Giada Del Baldo, Giulia Catassi, Andrea Faragalli, Marina Aloi, Matteo Bramuzzo, Giulia D’Arcangelo, Enrico Felici, Maurizio Fuoti, Sara Lega, Roberto Panceri, Maria Pastore, Francesca Penagini, Rosaria Gesuita, Carlo Catassi. Factors associated with quality of life in Italian children and adolescents with IBD. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-97661-1
|
| 10 |
Haiyang Wang, Xiaojing Zhao, Xiufang Cui, Meifeng Wang, Chunhua Jiao, Jiajia Li, Yan Yang, Yi Li, Hongjie Zhang. A Pilot Study of Clinical Evaluation and Formation Mechanism of Irritable Bowel Syndrome-like Symptoms in Inflammatory Bowel Disease Patients in Remission. Journal of Neurogastroenterology and Motility 2021; 27(4): 612 doi: 10.5056/jnm20151
|
| 11 |
Nasir Abbas, Mahrukh Shakil, Zeeshan Akhtar Rana, Sardar Basharat Ali, Ammad Ayub Awan, Saman Gul. A Systematic Review of the Role of Diet in Ulcerative Colitis. Cureus 2023; doi: 10.7759/cureus.39350
|
| 12 |
Melaku Ashagrie Belete, Selamyhun Tadesse, Mihret Tilahun, Alemu Gedefie, Agumas Shibabaw, Zewudu Mulatie, Muluken Amare Wudu, Saba Gebremichael, Habtu Debash, Mihreteab Alebachew, Ermiyas Alemayehu. Long noncoding RNAs and circular RNAs as potential diagnostic biomarkers of inflammatory bowel diseases: a systematic review and meta-analysis. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1362437
|
| 13 |
Renata de Sá Brito Fróes, André da Luz Moreira, Antonio José de V. Carneiro, Jessica P. L. Moreira, Ronir R. Luiz, Adriana Maria Hilu de Barros Moreira, Camila Cesar Monnerat, Heitor Siffert Pereira de Souza, Ana Teresa Pugas Carvalho. Prevalence, Indirect Costs, and Risk Factors for Work Disability in Patients with Crohn’s Disease at a Tertiary Care Center in Rio de Janeiro. Digestive Diseases and Sciences 2021; 66(9): 2925 doi: 10.1007/s10620-020-06646-z
|
| 14 |
Jana Langbrandtner, Gero Steimann, Christoph Reichel, Bernd Bokemeyer, Angelika Hüppe. Erwerbstätig mit chronisch entzündlicher
Darmerkrankung –Herausforderungen im Arbeitsleben und
unterstützende Maßnahmen zur Bewältigung. Die Rehabilitation 2022; 61(02): 97 doi: 10.1055/a-1581-6497
|
| 15 |
Tiziana Larussa, Danilo Flauti, Ludovico Abenavoli, Luigi Boccuto, Evelina Suraci, Raffaella Marasco, Maria Imeneo, Francesco Luzza. The Reality of Patient-Reported Outcomes of Health-Related Quality of Life in an Italian Cohort of Patients with Inflammatory Bowel Disease: Results from a Cross-Sectional Study. Journal of Clinical Medicine 2020; 9(8): 2416 doi: 10.3390/jcm9082416
|
| 16 |
Amosy Ephreim M’Koma. Inflammatory Bowel Disease: Clinical Diagnosis and Surgical Treatment-Overview. Medicina 2022; 58(5): 567 doi: 10.3390/medicina58050567
|
| 17 |
Nishaanth Dalavaye, Simon Erridge, Martha Nicholas, Manaswini Pillai, Lara Bapir, Carl Holvey, Ross Coomber, James J Rucker, Jonathan Hoare, Mikael H Sodergren. The effect of medical cannabis in inflammatory bowel disease: analysis from the UK Medical Cannabis Registry. Expert Review of Gastroenterology & Hepatology 2023; 17(1): 85 doi: 10.1080/17474124.2022.2161046
|
| 18 |
Anupam Kumar Singh, Daya Krishna Jha, Anuraag Jena, Praveen Kumar-M, Shaji Sebastian, Vishal Sharma. Hyperbaric oxygen therapy in inflammatory bowel disease: a systematic review and meta-analysis. European Journal of Gastroenterology & Hepatology 2021; 33(1S): e564 doi: 10.1097/MEG.0000000000002164
|
| 19 |
Rogério Serafim Parra, Júlio Maria Fonseca Chebli, Natália Sousa Freitas Queiroz, Aderson Omar Mourão Cintra Damião, Matheus Freitas Cardoso de Azevedo, Liliana Andrade Chebli, Erika Ruback Bertges, Antonio José Tiburcio Alves Junior, Orlando Ambrogini Junior, Bianca Loyo Pona Schiavetti da Silva, Marcio Lubini, Mauro Bafutto, Cristina Flores, Eduardo Garcia Vilela, Sandra Felice Boratto, Newton Luiz Tricarico Gasparetti Junior, Flavio Steinwurz, Nayara Salgado Carvalho, Omar Féres, José Joaquim Ribeiro da Rocha. Long-term effectiveness and safety of ustekinumab in bio-naïve and bio-experienced anti-tumor necrosis factor patients with Crohn’s disease: a real-world multicenter Brazilian study. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02280-3
|
| 20 |
Rogerio Serafim Parra, Sandro da Costa Ferreira, Vanessa Foresto Machado, Cintia Maura Caseiro Nigro, José Joaquim Ribeiro da Rocha, Luiz Ernesto de Almeida Troncon, Omar Feres. Access to High-Cost Biological Agents: Perceptions of Brazilian Patients with Inflammatory Bowel Diseases. Journal of Clinical Medicine 2023; 12(7): 2672 doi: 10.3390/jcm12072672
|
| 21 |
Parichat Thapwong, Christine Norton, Emma Rowland, Noora Farah, Wladyslawa Czuber‐Dochan. A systematic review of the impact of inflammatory bowel disease (IBD) on family members. Journal of Clinical Nursing 2023; 32(9-10): 2228 doi: 10.1111/jocn.16446
|
| 22 |
Ziyun Gao, Pei Wang, Jie Hong, Yuqing Yan, Tianying Tong, Bin Wu, Jun Hu, Zhenhua Wang. Health-related quality of life among Chinese patients with Crohn’s disease: a cross-sectional survey using the EQ-5D-5L. Health and Quality of Life Outcomes 2022; 20(1) doi: 10.1186/s12955-022-01969-z
|
| 23 |
Zhijie Ding, Erik Muser, James Izanec, Rina Lukanova, James Kershaw, Adam Roughley. Work-Related Productivity Loss and Associated Indirect Costs in Patients With Crohn’s Disease or Ulcerative Colitis in the United States. Crohn's & Colitis 360 2022; 4(3) doi: 10.1093/crocol/otac023
|
| 24 |
Daisuke Nakai, Masateru Miyake. The change of the electrophysiological parameters using human intestinal tissues from ulcerative colitis and Crohn's disease. Journal of Pharmacological Sciences 2022; 150(2): 90 doi: 10.1016/j.jphs.2022.07.006
|
| 25 |
Julio Maria Fonseca Chebli, Rogério Serafim Parra, Cristina Flores, Antonio Carlos Moraes, Rodrigo Bremer Nones, Tarcia Nogueira Ferreira Gomes, Ana Maria Bravo Perdomo, Gustavo Scapini, Cyrla Zaltman. Effectiveness and Safety of Ustekinumab for Moderate to Severely Active Crohn’s Disease: Results from an Early Access Program in Brazil. Journal of Clinical Medicine 2022; 11(21): 6481 doi: 10.3390/jcm11216481
|
| 26 |
Yazed AlRuthia, Majid Almadi, Abdulrahman Aljebreen, Nahla Azzam, Wejdan Alsharif, Hala Alrasheed, Ghadah Almuaythir, Maria Saeed, Baraa HajkhderMullaissa, Othman Alharbi. The cost-effectiveness of biologic versus non-biologic treatments and the health-related quality of life among a sample of patients with inflammatory bowel disease in a tertiary care center in Saudi Arabia. Journal of Medical Economics 2020; 23(10): 1102 doi: 10.1080/13696998.2020.1791889
|
| 27 |
Julian Panés, Séverine Vermeire, Geert R. D'Haens, Silvio Danese, Fernando Magro, Maciej Nazar, Manuela Le Bars, Marjolein Lahaye, Lioudmila Ni, Ivana Bravatà, Daniel R. Gaya, Laurent Peyrin‐Biroulet, Axel Dignass. Ustekinumab improves health‐related quality of life in patients with moderate‐to‐severe Crohn's disease: Results up to Week 104 of the STARDUST trial. United European Gastroenterology Journal 2023; 11(5): 410 doi: 10.1002/ueg2.12384
|
| 28 |
Niels Teich, Michael Bläker, Frank Holtkamp-Endemann, Eric Jörgensen, Andreas Stallmach, Susanne Hohenberger. Effect of Originator Infliximab Treatment on Disease-Related Hospitalizations, Work Productivity and Activity Impairment, and Health Resource Utilization in Patients with Crohn’s Disease in a Real-Life Setting: Results of a Prospective Multicenter Study in Germany. Inflammatory Intestinal Diseases 2021; 6(1): 48 doi: 10.1159/000512159
|
| 29 |
Paulina Nuñez F, Uma Mahadevan, Rodrigo Quera, Constanza Bay, Patricio Ibañez. Treat-to-target approach in the management of inflammatory Bowel disease. Gastroenterología y Hepatología (English Edition) 2021; 44(4): 312 doi: 10.1016/j.gastre.2020.06.023
|
| 30 |
Elizabeth Dent, Nicola Davinson, Stephanie Wilkie. The impact of gastrointestinal conditions on psychosocial factors associated with the biopsychosocial model of health: A scoping review. Applied Psychology: Health and Well-Being 2022; 14(2): 626 doi: 10.1111/aphw.12323
|
| 31 |
Hassan Karami, Maryam Shirvani Shiri, Farbod Ebadi Fard Azar, Kamran Bagheri Lankarani, Sulmaz Ghahramani, Aziz Rezapour, Maryam Tatari, Zahra Heidari Javargi. Factors associated with health-related quality of life in patients with Crohn's disease in Iran: A prospective observational study. Frontiers in Medicine 2023; 9 doi: 10.3389/fmed.2022.1091330
|
| 32 |
Rodrigo Bremer Nones, Eron Fabio Miranda, Gustavo de Nardi Marçal, Fernanda da Silva Barbosa Baraúna, Marcela Rocha Loures, Paula Cenira Senger, Daniela Oliveira Magro, Paulo Gustavo Kotze. Infliximab serum concentrations in luminal Crohn's disease and its relationship with disease activity: A multicentric cross-sectional study. Gastroenterología y Hepatología 2023; doi: 10.1016/j.gastrohep.2023.12.011
|
| 33 |
Rafaela Matos, Leonor Lencastre, Vânia Rocha, Sandra Torres, Filipa Vieira, Maria Raquel Barbosa, Jorge Ascenção, Marina Prista Guerra. Quality of life in patients with inflammatory bowel disease: the role of positive psychological factors. Health Psychology and Behavioral Medicine 2021; 9(1): 989 doi: 10.1080/21642850.2021.2007098
|
| 34 |
Karina Nascimento da Silva, Aline Garnevi Fávero, William Ribeiro, Caroline Marcantonio Ferreira, Patrícia Sartorelli, Leonardo Cardili, Cristina Stewart Bogsan, Joice Naiara Bertaglia Pereira, Rita de Cássia Sinigaglia, Andréa Cristina de Moraes Malinverni, Ana Paula Ribeiro Paiotti, Sender Jankiel Miszputen, Orlando Ambrogini-Júnior. Effects of kefir fermented milk beverage on sodium dextran sulfate (DSS)-induced colitis in rats. Heliyon 2023; 9(1): e12707 doi: 10.1016/j.heliyon.2022.e12707
|
| 35 |
Sandro da Costa Ferreira, Lílian Rose Otoboni Aprile, Rogério Serafim Parra, Marley Ribeiro Feitosa, Patrícia Picardi Morais de Castro, Gleici de Castro da Silva Perdoná, Omar Feres, José Joaquim Ribeiro da Rocha, Luiz Ernesto de Almeida Troncon. Factors associated with surgical resection in patients with Crohn’s disease: long-term evaluation. Acta Cirúrgica Brasileira 2024; 39 doi: 10.1590/acb391924
|
| 36 |
Jeremy Dunford, Andrea T. Lee, Michael M. Morgan. Tetrahydrocannabinol (THC) Exacerbates Inflammatory Bowel Disease in Adolescent and Adult Female Rats. The Journal of Pain 2021; 22(9): 1040 doi: 10.1016/j.jpain.2021.02.014
|
| 37 |
Takayuki Yamamoto, Hiroshi Nakase, Kenji Watanabe, Shinichiro Shinzaki, Noritaka Takatsu, Toshimitsu Fujii, Ryuichi Okamoto, Katsuyoshi Matsuoka, Akihiro Yamada, Reiko Kunisaki, Minoru Matsuura, Hisashi Shiga, Shigeki Bamba, Yohei Mikami, Takahiro Shimoyama, Satoshi Motoya, Takehiro Torisu, Taku Kobayashi, Naoki Ohmiya, Masayuki Saruta, Koichiro Matsuda, Takayuki Matsumoto, Atsuo Maemoto, Yoko Murata, Shinichi Yoshigoe, Shinya Nagasaka, Tsutomu Yajima, Tadakazu Hisamatsu, Masakazu Nagahori, Tatsu Yukawa, Daisuke Saito, Mikio Kawai, Atsushi Masamune, Mitsuo Nagasaka, Tomoe Kazama. Diagnosis and Clinical Features of Perianal Lesions in Newly Diagnosed Crohn’s Disease: Subgroup Analysis from Inception Cohort Registry Study of Patients with Crohn’s Disease (iCREST-CD). Journal of Crohn's and Colitis 2023; 17(8): 1193 doi: 10.1093/ecco-jcc/jjad038
|
| 38 |
Paulina Nuñez F, Uma Mahadevan, Rodrigo Quera, Constanza Bay, Patricio Ibañez. Treat-to-target approach in the management of inflammatory Bowel disease. Gastroenterología y Hepatología 2021; 44(4): 312 doi: 10.1016/j.gastrohep.2020.06.032
|
| 39 |
Ligia Yukie Sassaki, Sender J Miszputen, Roberto Luiz Kaiser Junior, Wilson R Catapani, Mauro Bafutto, António S Scotton, Cyrla Zaltman, Julio Pinheiro Baima, Hagata S Ramos, Mikaell Alexandre Gouvea Faria, Carolina D Gonçalves, Isabella Miranda Guimaraes, Cristina Flores, Heda M B S Amarante, Rodrigo Bremer Nones, José Miguel Luz Parente, Murilo Moura Lima, Júlio Maria Chebli, Maria de Lourdes Abreu Ferrari, Julia F Campos, Maria G P Sanna, Odery Ramos, Rogério Serafim Parra, Jose J R da Rocha, Omar Feres, Marley R Feitosa, Rosana Fusaro Caratin, Juliana Tosta Senra, Genoile Oliveira Santana. Real-world treatment patterns and disease control over one year in patients with inflammatory bowel disease in Brazil. World Journal of Gastroenterology 2021; 27(23): 3396-3412 doi: 10.3748/wjg.v27.i23.3396
|
| 40 |
Parichat Thapwong, Christine Norton, Helen Terry, Wladyslawa Czuber-Dochan. Impact of inflammatory bowel disease on partners: a qualitative study. Gastrointestinal Nursing 2022; 20(3): 40 doi: 10.12968/gasn.2022.20.3.40
|
| 41 |
Rogério Serafim PARRA, Marley Ribeiro FEITOSA, Sandro da Costa FERREIRA, José Joaquim Ribeiro da ROCHA, Luiz Ernesto de Almeida TRONCON, Omar FÉRES. ANEMIA AND IRON DEFICIENCY IN INFLAMMATORY BOWEL DISEASE PATIENTS IN A REFERRAL CENTER IN BRAZIL: PREVALENCE AND RISK FACTORS. Arquivos de Gastroenterologia 2020; 57(3): 272 doi: 10.1590/s0004-2803.202000000-51
|